Years increasing dividends4.8
#36 of 10048 reported increase years. Years / 10, capped at 5 points.
Nanalyze Dividend
MDT Medtronic plc
A diversified medical-device franchise supports a recurring demand thesis. Innovation cycles, regulation and currency movements affect earnings.
Q-score estimate16.0#41 of 100 assessed stocks
Years increasing dividends and market capitalization contribute the most. 5-year dividend growth is the largest constraint. Independent estimate from dated inputs, not a publisher Q-score.
Hypothetical investment
Growth of $10,000
Dividends reinvested · no additional contributions
MDT would be worth$8,3715-year growth · as of Sep 18, 2026
S&P 500 (SPY)$18,763Same $10,000 · same dates
Total gain / loss−$1,629-16.3% total return
MDTS&P 500 (SPY)
Sep 20, 2021 · $10,000 investedSep 18, 2026
Based on adjusted market prices through the latest available completed session, before personal taxes and trading costs.
Checking the latest completed session…
Market performance
Total return
Price movement plus reinvested distributions, compared with SPY.
-16.3% over 5 years
1 YEAR TOTAL RETURN-0.5%#63 return rank · 100 peers
Price-3.6%
Dividend+3.1%
Net loss; shares not shown.
5 YEARS TOTAL RETURN-16.3%-3.5% / yr annualized#84 return rank · 99 peers
Price-28.4%
Dividend+12.1%
Net loss; shares not shown.
Dividend includes all distributions and reinvestment.
Sep 20, 2021Sep 18, 2026
Total return-16.29%
S&P 500 (SPY)+87.63%
Annualized return-3.50%
Largest drawdown-43.47%
Transparent factor breakdown
Official framework Why the Q-score estimate is 16.0
Each rank compares this stock with the 100 assessed stocks in the Nanalyze collection.
Market capitalization4.1
#26 of 100$107.41 billion. 2 × log10(market cap in USD billions), limited to 0–5 points.
Dividend yield3.9
#23 of 1003.43%. 2 × (yield % − 1.5), limited to −2–5 points.
Payout ratio0.9
#78 of 10076.14%. (90 − payout %) / 15, limited to −2–5 points. Zero or negative payout receives −2 rather than a false coverage reward.
International sales2.5
#31 of 10047.80% source geographic share. At most 25%: −1 point; above 25% through 50%: 2.5; above 50%: 5. A verified upper bound is usable only when entirely within the lowest band.
5-year dividend growth-0.8
#90 of 1002.71%. (5-year growth % − 5) / 3, limited to −2–5 points.
10-year dividend growth0.6
#71 of 1005.29%. (10-year growth % − 4) / 2, limited to −2–5 points.
Independent estimate · assessed October 10, 2026. All 100 research stocks use the same rules. Each component is rounded to one decimal before summing; equal totals share a rank. These scores are not Nanalyze’s published Q-scores. Full method
Supplied Quantigence ALL calculator; imported 2026-09-23; effective date unstated. Quantigence Q-Score Calculator - ALL.csv, row 62; source symbol MDT. Supplied publisher total: 13.9 (separate scale; not used in this ranking).
Inputs are a supplied calculator snapshot, not live values; its effective date is unstated. Geography and payout definitions are retained as supplied.
Why it is in this section
A diversified medical-device franchise supports a recurring demand thesis.
What to investigate
Innovation cycles, regulation and currency movements affect earnings.
Independent selection; creator ownership or endorsement has not been verified. NOBL screens for a 25-year dividend-increase record; index treatment can include predecessor history. Q-score not assessed.